22nd Century Group logo.jpg
22nd Century Group to Announce Fourth Quarter and Full Year 2021 Results on March 1, 2022
February 03, 2022 09:20 ET | 22nd Century Group, Inc
BUFFALO, N.Y., Feb. 03, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco,...
22nd Century Group Supports Upcoming FDA Action Banning Menthol in Highly Addictive Combustible Cigarettes
February 01, 2022 12:30 ET | 22nd Century Group, Inc
BUFFALO, N.Y., Feb. 01, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco,...
22nd Century Group logo.jpg
22nd Century Group Announces First Production of VLN® Cigarettes for Retail Sale
January 26, 2022 11:00 ET | 22nd Century Group, Inc
BUFFALO, N.Y., Jan. 26, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco,...
22nd Century Group logo.jpg
22nd Century Group Appoints James A. Mish to Its Board of Directors
January 21, 2022 08:00 ET | 22nd Century Group, Inc
BUFFALO, N.Y, Jan. 21, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and...
22nd Century Launching the First Reduced Nicotine Cigarette Authorized by the FDA That Helps You Smoke Less
January 18, 2022 08:00 ET | 22nd Century Group, Inc
FDA Mandates Addition of Extra Claim “Helps You Smoke Less” on PackagingU.S. Pilot Market Launch with Major Retail Partner by March 2022 BUFFALO, N.Y., Jan. 18, 2022 (GLOBE NEWSWIRE) -- On December...
22nd Century Group logo.jpg
22nd Century Group to Participate in Fireside Chat Events with Alliance Global Partners Equity Analyst Aaron Grey and Cowen Equity Analyst Vivien Azer on Wednesday, January 5, 2022
January 03, 2022 14:23 ET | 22nd Century Group, Inc
BUFFALO, N.Y., Jan. 03, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco,...
22nd Century Group logo.jpg
22nd Century Ready to Provide Full Commercial Support to New Zealand’s Plan to Reduce Nicotine Content of All Cigarettes
December 10, 2021 09:20 ET | 22nd Century Group, Inc
New Zealand Ministry of Health announced aggressive measures to reduce smoking, including a reduced nicotine mandate by 2025 22nd Century fully engaged and ready to support New Zealand’s government...
22nd Century Group Announces CFO Transition
November 19, 2021 08:30 ET | 22nd Century Group, Inc
Richard Fitzgerald Joins as Chief Financial Officer John Franzino Transitions to Chief Administrative Officer BUFFALO, N.Y., Nov. 19, 2021 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq:...
22nd Century Group logo.jpg
22nd Century Group Applauds Califf Nomination as FDA Commissioner
November 15, 2021 09:20 ET | 22nd Century Group, Inc
Califf Is a Longtime Proponent of Tobacco Control; Indicated Nicotine Mandate Should Be Key Priority For FDAMRTP Authorization And Launch of VLN® Will Serve as Vanguard for FDA’s Proposed Nicotine Cap...
22nd Century Group logo.jpg
22nd Century Group VP of Regulatory Science to Participate in FDLI Panel in Response to Recent FDA Action on Comprehensive Plan and Reduced Nicotine Mandate
October 13, 2021 16:01 ET | 22nd Century Group, Inc
Company Supports This Week’s Positive FDA Action on E-Cigarettes, Demonstrating the Agency’s Commitment to Providing Adult Smokers with Alternatives to Highly Addictive CigarettesApplauds FDA’s Active...